マーケットレポート詳細
超音波診断・治療装置の世界市場：2028年に至る領域別、技術別予測
Ultrasound Market by Technology (2D, 3D, Doppler, Contrast-Enhanced, HIFU, ESWL), Component (Workstation, Probe), Type (Cart, Handheld, PoC), Application (OB/GYN, CVD, Urology, Ortho), End User (Hospitals, Clinics, ASCs) & Region - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年8月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文259ページになります。
- 商品コード：MAM3370
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
超音波診断・治療装置の世界市場規模は2023年の85億ドルから、2028年までに116億ドルへと拡大し、2023年から2028年にかけての市場の平均年成長率は6.3%で推移することが見込まれています。
レポートは超音波診断・治療装置の世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（技術別市場、ディスプレイタイプ別市場、等）を中心に構成されています。また競合状況、主要企業情報（15社）、市場ダイナミクス、業界構造分析などの分析も加味し、超音波診断・治療装置市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆超音波診断・治療装置の世界市場予測2021-2028年
・市場規模(US$)
◆技術別、市場-2028年
診断用超音波
・2D超音波
・3D/4D超音波
・ドップラー超音波
・造影超音波
治療用超音波
・HIFU
・ESWL
※(市場規模US$)
◆ディスプレイタイプ別、市場-2028年
・カラー
・白黒
※(市場規模US$)
◆ポータビリティ別、市場-2028年
・トロリー/カートベース超音波システム
・コンパクト/ハンドヘルド超音波システム
・ポイントオブケア（POC）超音波システム
※(市場規模US$)
◆用途別、市場-2028年
・放射線/汎用イメージング
・心臓病
・産婦人科
・泌尿器科
・血管
・整形外科/筋骨格
・疼痛管理
・その他用途
※(市場規模US$)
◆コンポーネント別、市場-2028年
・トランスデューサ/プローブ
-曲線プローブ/コンベックスアレイ
-リニアアレイ
-フェーズドアレイ
-その他アレイタイプ
・ワークステーション
・その他コンポーネント
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・病院/外科センター/診断センター
・マタニティセンター
・外来ケアセンター
・研究/学術機関
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
※国別に技術別、タイプ別 の細分化データ掲載
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・業界構造分析（ファイブフォース分析）
・規制分析
・費用償還シナリオ
・バリューチェーン分析
・サプライチェーン分析
・特許分析
・貿易分析
・ケーススタディ分析
・価格分析
・競合状況
・市場シェア分析
◆超音波診断・治療装置の主要企業プロフィール動向
・GE HEALTHCARE
・KONINKLIJKE PHILIPS N.V.
・キャノンメディカルシステムズ株式会社
・SIEMENS AG
・富士フィルム株式会社
・HOLOGIC, INC.
・SAMSUNG ELECTRONICS CO., LTD.
・MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
・ESAOTE SPA
・CHISON MEDICAL TECHNOLOGIES CO., LTD.
・NEUSOFT CORPORATION
・MOBISANTE, INC.
・CLARIUS
・MEDGYN PRODUCTS, INC.
・PROMED TECHNOLOGY CO., LTD.
（その他企業）
・WHITE EAGLE SONIC TECHNOLOGIES, INC.
・TELEMED ULTRASOUND
・SHENZHEN RICSO TECHNOLOGY CO., LTD.
・GUANGDONG YOUKEY MEDICAL CO., LTD.
・ECHONOUS INC.
・SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.
・SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENTS CO., LTD. (SIUI)
・BUTTERFLY NETWORK, INC.
・ALPINION MEDICAL SYSTEMS CO., LTD.
・EDAN INSTRUMENTS, INC.
（全259頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE 22
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 RESEARCH LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 ULTRASOUND MARKET: RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 PRIMARY SOURCES
2.1.2.2 KEY INDUSTRY INSIGHTS
2.1.2.3 BREAKDOWN OF PRIMARIES
・ FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
・ FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
・ FIGURE 5 MARKET SIZE ESTIMATION FOR ULTRASOUND MARKET: APPROACH 1 (COMPANY REVENUE ESTIMATION)
・ FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF GE HEALTHCARE
2.2.1.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
2.2.1.3 ULTRASOUND MARKET: TOP-DOWN APPROACH
2.2.1.4 CAGR PROJECTION
・ FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
2.3 DATA VALIDATION APPROACH
・ FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.6.1 ULTRASOUND MARKET: RISK ASSESSMENT
2.7 GROWTH RATE ASSUMPTIONS
2.8 ULTRASOUND MARKET: RECESSION IMPACT
3 EXECUTIVE SUMMARY
・ FIGURE 9 ULTRASOUND MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
・ FIGURE 10 ULTRASOUND MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 11 ULTRASOUND MARKET, BY PORTABILITY, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 ULTRASOUND MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 GEOGRAPHICAL SNAPSHOT OF ULTRASOUND MARKET
4 PREMIUM INSIGHTS
4.1 ULTRASOUND MARKET OVERVIEW
・ FIGURE 14 INCREASING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT RISE IN SURGICAL PROCEDURES TO DRIVE MARKET 43
4.2 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY (USD MILLION)
・ FIGURE 15 DIAGNOSTIC ULTRASOUND SEGMENT TO HOLD LARGEST SHARE
4.3 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER
・ FIGURE 16 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 ULTRASOUND MARKET, BY DISPLAY TYPE
・ FIGURE 17 COLOR ULTRASOUND SEGMENT TO COMMAND LARGEST SHARE TILL 2028
4.5 GEOGRAPHIC SNAPSHOT OF ULTRASOUND MARKET
・ FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 19 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 INCREASING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT RISE IN SURGICAL PROCEDURES
5.2.1.2 GROWING PATIENT PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
5.2.1.3 RISING TECHNOLOGICAL ADVANCEMENTS IN ULTRASOUND DEVICES
5.2.1.4 GROWING PUBLIC-PRIVATE INVESTMENTS FOR PRODUCT COMMERCIALIZATION 49
5.2.1.5 INCREASING ESTABLISHMENT OF HOSPITALS AND DIAGNOSTIC CENTERS
5.2.2 RESTRAINTS
5.2.2.1 UNFAVORABLE REIMBURSEMENTS
5.2.2.2 HIGH OPERATING COSTS
5.2.3 OPPORTUNITIES
5.2.3.1 GROWING APPLICATIONS OF THERAPEUTIC ULTRASOUND
5.2.3.2 HIGH GROWTH POTENTIAL OF EMERGING MARKETS
5.2.3.3 DEVELOPMENT OF POC ULTRASOUND SYSTEMS
5.2.4 CHALLENGES
5.2.4.1 GROWING END-USER PREFERENCE FOR REFURBISHED EQUIPMENT
5.2.4.2 SHORTAGE OF SKILLED SONOGRAPHERS
5.3 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 1 ULTRASOUND MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS 54
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 REGULATORY TRENDS
5.5 REGULATORY ANALYSIS
5.5.1 NORTH AMERICA
5.5.1.1 US
・ TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
・ TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.1.2 CANADA
・ TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPE
5.5.3 ASIA PACIFIC
5.5.3.1 JAPAN
・ TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.5.3.2 CHINA
・ TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.5.3.3 INDIA
5.6 REIMBURSEMENT SCENARIO
・ TABLE 7 MEDICAL REIMBURSEMENT CPT CODES FOR ULTRASOUND PROCEDURES IN US (AS OF 2021)
5.7 ECOSYSTEM MAPPING
5.8 VALUE CHAIN ANALYSIS
5.8.1 RESEARCH & PRODUCT DEVELOPMENT
5.8.2 RAW MATERIAL AND MANUFACTURING
5.8.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES
・ FIGURE 20 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.9 SUPPLY CHAIN ANALYSIS
5.9.1 PROMINENT COMPANIES
5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.9.3 END USERS
・ TABLE 8 ULTRASOUND MARKET: SUPPLY CHAIN ECOSYSTEM
・ FIGURE 21 ULTRASOUND MARKET: SUPPLY CHAIN ANALYSIS
5.10 PATENT ANALYSIS
・ FIGURE 22 PATENT DETAILS FOR ULTRASOUND (JANUARY 2013–JUNE 2023)
・ FIGURE 23 PATENTS FOR DIAGNOSTIC ULTRASOUND SYSTEMS (JANUARY 2013–JUNE 2023)
・ FIGURE 24 PATENTS FOR THERAPEUTIC ULTRASOUND SYSTEMS (JANUARY 2013–JUNE 2023)
5.11 TRADE ANALYSIS
5.11.1 ULTRASOUND MARKET: TRADE ANALYSIS
・ TABLE 9 IMPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2018–2022 (USD)
・ TABLE 10 EXPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2018–2022 (USD)
5.12 KEY CONFERENCES AND EVENTS
・ TABLE 11 ULTRASOUND MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025)
5.13 TECHNOLOGY ANALYSIS
5.14 CASE STUDY ANALYSIS
・ TABLE 12 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
・ TABLE 13 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING ULTRASOUND TECHNIQUES
5.15 PRICING ANALYSIS
・ TABLE 14 REGIONAL PRICE RANGE FOR ULTRASOUND SYSTEMS
6 ULTRASOUND MARKET, BY TECHNOLOGY 74
6.1 INTRODUCTION
・ TABLE 15 ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
6.2 DIAGNOSTIC ULTRASOUND
・ TABLE 16 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 17 DIAGNOSTIC ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 18 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
・ TABLE 19 DIAGNOSTIC ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
・ TABLE 20 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 21 DIAGNOSTIC ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
6.2.1 2D ULTRASOUND
6.2.1.1 STRONG DEMAND IN EMERGING ECONOMIES TO DRIVE MARKET
・ TABLE 22 2D ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 3D & 4D ULTRASOUND
6.2.2.1 GREATER DIAGNOSTIC ACCURACY AND IMPROVED IMAGING CAPABILITIES TO BOOST DEMAND
・ TABLE 23 3D & 4D ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.3 DOPPLER ULTRASOUND
6.2.3.1 GROWING APPLICATIONS IN PAIN MANAGEMENT, CARDIOVASCULAR IMAGING, AND EMERGENCY CARE TO DRIVE MARKET
・ TABLE 24 DOPPLER ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.4 CONTRAST-ENHANCED ULTRASOUND 81
6.2.4.1 AVAILABILITY OF TECHNOLOGICALLY ADVANCED INSTRUMENTS TO SUPPORT GROWTH
・ TABLE 25 CONTRAST-ENHANCED ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 THERAPEUTIC ULTRASOUND
・ TABLE 26 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 27 THERAPEUTIC ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 28 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
・ TABLE 29 THERAPEUTIC ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
・ TABLE 30 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 31 THERAPEUTIC ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
6.3.1 HIGH-INTENSITY FOCUSED ULTRASOUND
6.3.1.1 PROMISING RESULTS ASSOCIATED WITH HIFU IN CANCER TREATMENT TO DRIVE MARKET
・ TABLE 32 HIGH-INTENSITY FOCUSED ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
6.3.2.1 GROWING EMPHASIS ON MINIMALLY INVASIVE TREATMENT OF KIDNEY & GALLBLADDER STONES TO DRIVE DEMAND FOR ESWL
・ TABLE 33 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY MARKET, BY REGION, 2021–2028 (USD MILLION)
7 ULTRASOUND MARKET, BY DISPLAY
7.1 INTRODUCTION
・ TABLE 34 ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
7.2 COLOR ULTRASOUND DEVICES
7.2.1 RISING AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE MARKET
・ TABLE 35 COLOR ULTRASOUND DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 BLACK & WHITE ULTRASOUND DEVICES
7.3.1 ASIA PACIFIC REGION TO SHOW SUSTAINED DEMAND
・ TABLE 36 BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
8 ULTRASOUND MARKET, BY PORTABILITY 91
8.1 INTRODUCTION
・ TABLE 37 ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
8.2 TROLLEY/CART-BASED ULTRASOUND SYSTEMS
8.2.1 RISING USAGE OF TROLLEY-BASED SYSTEMS IN ACUTE & EMERGENCY CARE TO DRIVE MARKET
・ TABLE 38 TROLLEY/CART-BASED ULTRASOUND SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3 COMPACT/HANDHELD ULTRASOUND SYSTEMS
8.3.1 AFFORDABILITY AND PROCEDURAL & TECHNICAL BENEFITS TO DRIVE MARKET
・ TABLE 39 COMPACT/HANDHELD ULTRASOUND SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
8.4 POC ULTRASOUND SYSTEMS
8.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST DEMAND
・ TABLE 40 POC ULTRASOUND SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
9 ULTRASOUND MARKET, BY APPLICATION 96
9.1 INTRODUCTION
・ TABLE 41 ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2 RADIOLOGICAL/GENERAL IMAGING APPLICATIONS
9.2.1 GROWING NUMBER OF IMAGE-GUIDED SURGERIES TO DRIVE MARKET
・ TABLE 42 ULTRASOUND MARKET FOR RADIOLOGICAL/GENERAL IMAGING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
9.3 CARDIOLOGICAL APPLICATIONS
9.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE MARKET
・ TABLE 43 ULTRASOUND MARKET FOR CARDIOLOGICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
9.4 OBSTETRIC/GYNECOLOGICAL APPLICATIONS
9.4.1 WIDE USAGE IN OB/GYN APPLICATIONS TO BOOST GROWTH
・ TABLE 44 ULTRASOUND MARKET FOR OBSTETRIC/GYNECOLOGICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
9.5 UROLOGICAL APPLICATIONS
9.5.1 GROWING PREVALENCE OF UROLOGICAL DISORDERS TO SUPPORT MARKET
・ TABLE 45 ULTRASOUND MARKET FOR UROLOGICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
9.6 VASCULAR APPLICATIONS
9.6.1 VASCULAR APPLICATIONS TO WITNESS HIGH GROWTH
・ TABLE 46 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
9.7 ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS
9.7.1 RISING PATIENT PREFERENCE FOR EARLY DIAGNOSIS TO DRIVE MARKET
・ TABLE 47 ULTRASOUND MARKET FOR ORTHOPEDIC & MUSCULOSKELETAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
9.8 PAIN MANAGEMENT APPLICATIONS
9.8.1 INCREASING USE IN TRAUMA & EMERGENCY CARE TO SUPPORT MARKET GROWTH
・ TABLE 48 ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
9.9 OTHER APPLICATIONS
・ TABLE 49 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
10 ULTRASOUND MARKET, BY COMPONENT 105
10.1 INTRODUCTION
・ TABLE 50 ULTRASOUND MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
10.2 TRANSDUCERS/PROBES
・ TABLE 51 ULTRASOUND TRANSDUCERS/PROBES MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 52 ULTRASOUND TRANSDUCERS/PROBES MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2.1 CURVILINEAR/CONVEX ARRAYS
10.2.1.1 GROWING ADOPTION OF POC ULTRASOUND TO SUPPORT GROWTH
・ TABLE 53 CURVILINEAR/CONVEX ARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2.2 LINEAR ARRAYS
10.2.2.1 RISING TARGET PATIENT POPULATION TO DRIVE MARKET
・ TABLE 54 LINEAR ARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2.3 PHASED ARRAYS
10.2.3.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
・ TABLE 55 PHASED ARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2.4 OTHER ARRAY TYPES
・ TABLE 56 OTHER ARRAY TYPES MARKET, BY REGION, 2021–2028 (USD MILLION)
10.3 WORKSTATIONS
10.3.1 GROWING DIAGNOSTIC PROCEDURAL VOLUMES TO FUEL DEMAND FOR WORKSTATIONS
・ TABLE 57 ULTRASOUND WORKSTATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
10.4 OTHER COMPONENTS
・ TABLE 58 OTHER ULTRASOUND COMPONENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
11 ULTRASOUND MARKET, BY END USER
11.1 INTRODUCTION
・ TABLE 59 ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS
11.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR ULTRASOUND
・ TABLE 60 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
11.3 MATERNITY CENTERS
11.3.1 INCREASED ADOPTION OF ADVANCED ULTRASOUND FOR OB/GYN APPLICATIONS TO BOOST GROWTH
・ TABLE 61 ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION, 2021–2028 (USD MILLION)
11.4 AMBULATORY CARE CENTERS
11.4.1 INCREASING EMPHASIS ON AMBULATORY CARE TO SUPPORT MARKET GROWTH
・ TABLE 62 ULTRASOUND MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)
11.5 RESEARCH & ACADEMIA
11.5.1 GROWING AVAILABILITY OF RESEARCH GRANTS & FUNDING TO DRIVE GROWTH
・ TABLE 63 ULTRASOUND MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2021–2028 (USD MILLION)
11.6 OTHER END USERS
・ TABLE 64 ULTRASOUND MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
12 ULTRASOUND MARKET, BY REGION
12.1 INTRODUCTION
・ TABLE 65 ULTRASOUND MARKET, BY REGION, 2021–2028 (USD MILLION)
12.2 NORTH AMERICA
・ FIGURE 25 NORTH AMERICA: ULTRASOUND MARKET SNAPSHOT
・ TABLE 66 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 67 NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 68 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 69 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 70 NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
・ TABLE 71 NORTH AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
・ TABLE 72 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 73 NORTH AMERICA: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
12.2.1 US
12.2.1.1 ADVANCED HEALTHCARE INFRASTRUCTURE AND FAVORABLE REGULATIONS TO DRIVE MARKET
・ TABLE 74 POCUS ULTRASOUND CPT CODES (2021)
・ TABLE 75 US: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 76 US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 77 US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.2.2 CANADA
12.2.2.1 GROWING AWARENESS ABOUT EARLY DISEASE DIAGNOSIS TO DRIVE MARKET 130
・ TABLE 78 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 79 CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 80 CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.3 EUROPE
・ TABLE 81 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 82 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 83 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 84 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 85 EUROPE: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
・ TABLE 86 EUROPE: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
・ TABLE 87 EUROPE: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 88 EUROPE: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.1 GERMANY
12.3.1.1 INCREASING HEALTHCARE EXPENDITURE AND GOVERNMENT SPENDING TO DRIVE MARKET
・ TABLE 89 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 90 GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 91 GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.3.2 FRANCE
12.3.2.1 INCREASING TARGET PATIENT POPULATION AND RISING NUMBER OF DIAGNOSTIC TESTS FOR CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 92 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 93 FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 94 FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.3.3 UK
12.3.3.1 GROWING GOVERNMENT INITIATIVES AND INCREASING INCIDENCES OF CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 95 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 96 UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 97 UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.3.4 ITALY
12.3.4.1 INCREASED AVAILABILITY OF REIMBURSEMENT COVERAGE FOR DIAGNOSTIC PROCEDURES TO DRIVE MARKET
・ TABLE 98 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 99 ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 100 ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.3.5 SPAIN
12.3.5.1 INCREASING PREVALENCE OF CANCER AND GROWING PRIVATE-PUBLIC FUNDING TO DRIVE MARKET
・ TABLE 101 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 102 SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 103 SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.3.6 REST OF EUROPE
・ TABLE 104 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 105 REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 106 REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.4 ASIA PACIFIC
・ FIGURE 26 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT
・ TABLE 107 ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 108 ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 109 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 110 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 111 ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
・ TABLE 112 ASIA PACIFIC: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
・ TABLE 113 ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 114 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.1 CHINA
12.4.1.1 INCREASING HEALTHCARE REFORMS AND RISING GOVERNMENT INVESTMENTS TO DRIVE MARKET
・ TABLE 115 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 116 CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 117 CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 FAST ADOPTION OF ADVANCED TECHNOLOGIES AND GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET
・ TABLE 118 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 119 JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 120 JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.4.3 INDIA
12.4.3.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES AND IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
・ TABLE 121 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 122 INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 123 INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.4.4 AUSTRALIA
12.4.4.1 GROWING HEALTHCARE SPENDING AND INCREASING INVESTMENTS IN RESEARCH TO DRIVE MARKET
・ TABLE 124 AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO
・ TABLE 125 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 126 AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 127 AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.4.5 SOUTH KOREA
12.4.5.1 WELL-DEVELOPED HEALTHCARE SYSTEM AND RISING AWARENESS OF DISEASES TO DRIVE MARKET
・ TABLE 128 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 129 SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 130 SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.4.6 REST OF ASIA PACIFIC
・ TABLE 131 REST OF ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 132 REST OF ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 133 REST OF ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.5 LATIN AMERICA
・ TABLE 134 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 135 LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 136 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 137 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 138 LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
・ TABLE 139 LATIN AMERICA: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
・ TABLE 140 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 141 LATIN AMERICA: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.1 BRAZIL
12.5.1.1 GREATER PURCHASING POWER AND FAVORABLE DEMOGRAPHIC CONDITIONS TO DRIVE MARKET
・ TABLE 142 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 143 BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 144 BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.5.2 MEXICO
12.5.2.1 INCREASED MEDICAL TOURISM AND BETTER GOVERNMENT HEALTHCARE INITIATIVES TO DRIVE MARKET
・ TABLE 145 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 146 MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 147 MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.5.3 REST OF LATIN AMERICA
・ TABLE 148 REST OF LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 149 REST OF LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 150 REST OF LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
12.6 MIDDLE EAST & AFRICA
12.6.1 GROWING MEDICAL TOURISM AND INCREASING QUALITY HEALTHCARE SYSTEMS TO DRIVE MARKET
・ TABLE 151 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 152 MIDDLE EAST & AFRICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 153 MIDDLE EAST & AFRICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 154 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2021–2028 (USD MILLION)
・ TABLE 155 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY PORTABILITY, 2021–2028 (USD MILLION)
・ TABLE 156 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 157 MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY END USER, 2021–2028 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 STRATEGIES ADOPTED BY KEY PLAYERS
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ULTRASOUND MARKET
13.3 REVENUE SHARE ANALYSIS
・ FIGURE 27 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN ULTRASOUND MARKET, 2022
13.4 MARKET SHARE ANALYSIS
・ FIGURE 28 MARKET SHARE ANALYSIS OF TOP PLAYERS IN ULTRASOUND MARKET, 2022
・ TABLE 158 ULTRASOUND MARKET: DEGREE OF COMPETITION
13.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
・ FIGURE 29 ULTRASOUND MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 185
13.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
13.6.1 PROGRESSIVE COMPANIES
13.6.2 STARTING BLOCKS
13.6.3 RESPONSIVE COMPANIES
13.6.4 DYNAMIC COMPANIES
・ FIGURE 30 ULTRASOUND MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
13.7 COMPETITIVE BENCHMARKING
・ TABLE 159 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS
・ TABLE 160 PRODUCT FOOTPRINT ANALYSIS 188
・ TABLE 161 REGIONAL FOOTPRINT ANALYSIS 189
13.8 COMPETITIVE SCENARIO AND TRENDS
・ TABLE 162 PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023
・ TABLE 163 DEALS, JANUARY 2020–JUNE 2023
・ TABLE 164 OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023
14 COMPANY PROFILES
14.1 KEY PLAYERS 193
(BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
14.1.1 GE HEALTHCARE
・ TABLE 165 GE HEALTHCARE: COMPANY OVERVIEW
・ FIGURE 31 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
14.1.2 KONINKLIJKE PHILIPS N.V.
・ TABLE 166 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
・ FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
14.1.3 CANON MEDICAL SYSTEMS CORPORATION
・ TABLE 167 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
・ FIGURE 33 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022)
14.1.4 SIEMENS AG
・ TABLE 168 SIEMENS AG: COMPANY OVERVIEW 206
・ FIGURE 34 SIEMENS AG: COMPANY SNAPSHOT (2022)
14.1.5 FUJIFILM CORPORATION
・ TABLE 169 FUJIFILM CORPORATION: COMPANY OVERVIEW
・ FIGURE 35 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
14.1.6 HOLOGIC, INC.
・ TABLE 170 HOLOGIC, INC.: COMPANY OVERVIEW
・ FIGURE 36 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
14.1.7 SAMSUNG ELECTRONICS CO., LTD.
・ TABLE 171 SAMSUNG ELECTRONICS CO., LTD.: COMPANY OVERVIEW
・ FIGURE 37 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)
14.1.8 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
・ TABLE 172 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
・ FIGURE 38 MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)
14.1.9 ESAOTE SPA
・ TABLE 173 ESAOTE SPA: COMPANY OVERVIEW 226
14.1.10 CHISON MEDICAL TECHNOLOGIES CO., LTD.
・ TABLE 174 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
14.1.11 NEUSOFT CORPORATION
・ TABLE 175 NEUSOFT CORPORATION: COMPANY OVERVIEW
・ FIGURE 39 NEUSOFT CORPORATION: COMPANY SNAPSHOT (2022)
14.1.12 MOBISANTE, INC.
・ TABLE 176 MOBISANTE, INC.: COMPANY OVERVIEW
14.1.13 CLARIUS
・ TABLE 177 CLARIUS: COMPANY OVERVIEW
14.1.14 MEDGYN PRODUCTS, INC.
・ TABLE 178 MEDGYN PRODUCTS, INC.: COMPANY OVERVIEW
14.1.15 PROMED TECHNOLOGY CO., LTD. 240
・ TABLE 179 PROMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
14.2 OTHER COMPANIES
14.2.1 WHITE EAGLE SONIC TECHNOLOGIES, INC.
14.2.2 TELEMED ULTRASOUND
14.2.3 SHENZHEN RICSO TECHNOLOGY CO., LTD.
14.2.4 GUANGDONG YOUKEY MEDICAL CO., LTD.
14.2.5 ECHONOUS INC.
14.2.6 SHENZHEN BIOCARE BIO-MEDICAL EQUIPMENT CO., LTD.
14.2.7 SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENTS CO., LTD. (SIUI)
14.2.8 BUTTERFLY NETWORK, INC.
14.2.9 ALPINION MEDICAL SYSTEMS CO., LTD.
14.2.10 EDAN INSTRUMENTS, INC.